Effects of entecavir and tenofovir disoproxil fumarate on the incidence and severity of COVID-19 in patients with chronic hepatitis B - BMC Infectious Diseases
Covid
Common HIV medication associated with improved COVID-19 outcomes
Dose matters: HIV drug could prevent coronaviruses, study finds
Oral Azvudine for hospitalised patients with COVID-19 and pre-existing conditions: a retrospective cohort study
Azvudine versus Paxlovid in COVID‐19: A systematic review and meta‐analysis
Azvudine versus paxlovid for oral treatment of COVID-19 in Chinese patients - BMC Infectious Diseases
Research shows how HIV drug could stop many coronavirus diseases
Darunavir ethanolate: Repurposing an anti-HIV drug in COVID-19 treatment
Efficacy and safety of azvudine in patients with COVID-19: A systematic review and meta-analysis
Oral Azvudine for hospitalised patients with COVID-19 and pre-existing conditions: a retrospective cohort study
Azvudine versus Paxlovid for oral treatment of COVID-19 in Chinese patients with pre-existing comorbidities
Effectiveness and safety of azvudine in older adults with mild and moderate COVID-19: a retrospective observational study - BMC Infectious Diseases
Comparison of azvudine, molnupiravir, and nirmatrelvir/ritonavir in adult patients with mild-to-moderate COVID-19: a retrospective cohort study
Murphy's Medicine Podcast: Episode One. SARS CoV2 Associated Neurocognitive Decline
SARS-Cov-2 Associated Neurocognitive Decline (SAND) Scan
Study Shows How Paxlovid Resistance Emerges in Persistent Infections
“This type of approach helped to improve HIV drugs, and we think it’s a good way to improve antivirals against SARS-CoV-2,” says Sho Iketani, PhD, assistant professor of medical sciences at Columbia University’s Vagelos College of Physicians and Surgeons and Aaron Diamond AIDS Research Center, who co-led the research with David D. Ho, MD, the Clyde '56 and Helen Wu Professor of Medicine, professor of microbiology & immunology, and director of the Aaron Diamond AIDS Research Center, and Haitao Yang, PhD, of ShanghaiTech University.
How monoclonal antibodies lost the fight with new COVID variants
Myocarditis complications more common after COVID infection than vaccination, 18-month data suggest | CIDRAP
COVID's Spike Protein Enhances Ability to Infect Brain - Neuroscience News
New vector vaccine against COVID-19 provides long-term protection
Postacute Sequelae of SARS-CoV-2 in Children
Long COVID Looks Different in Kids
Prevalence and co-occurrence of cognitive impairment in children and young people up to 12-months post infection with SARS-CoV-2 (Omicron variant) - PubMed
Characterizing Long COVID in Children and Adolescents
Study determines most common long COVID symptoms in children and teens
Proof long Covid in kids DOES exist and they suffer worse symptoms
Soluble IL-2R impairs muscle cell mitochondrial respiration in fatigued individuals with post-acute sequelae of COVID-19.
Updated COVID Vaccines Are Coming: Effectiveness, Who’s Eligible And More
Project NextGen
Multi-antigen intranasal vaccine protects against challenge with sarbecoviruses and prevents transmission in hamsters